9th DIA Cell and Gene Therapy Products Symposium in Japan

Development of Next-Generation Cell and Gene Products - Issues in Development of Existing Products and Prospects for Practical Application of Next Generation Products -

戻る Agenda

Session 4 : Considering the Price and Economic Viability of Regenerative Medicine Products

Session Chair(s)

Kiyoshi Okada, MD, PhD

Vice Director, Medical Ctr for Translational Research,Dept of Medical Innovation

Osaka University Hospital, Japan

Akiko Ikeda, RPh

KalVista Pharmaceuticals Japan K.K., Japan

Speaker(s)

Drug Lag & Loss in New Modalities

Takeshi Yanagimoto

Boston Consulting Group, Japan

Managing Director & Partner

Industrialization of Regenerative Medicine for the Global Market

Keita Komatsu

Ministry of Economy, Trade and Industry (METI), Japan

The Value and Price of Regenerative Medicine Products (from the Industry’s Perspective)

Hiroyuki Kanoh

MITSUI FUDOSAN Co., LTD, Japan

Senior Adviser, Laboratory & Office Group

Masayo Takahashi

Kobe City Eye Hospital / VCCT Inc., Japan

President